Related Experiment Video
Updated: May 5, 2026

14:56
An Experimental Paradigm for the Prediction of Post-Operative Pain PPOP
Published on: January 27, 2010
21.3K
PREDICTing Post-Embolization Syndrome after uterine fibroid embolization: the PREDICT-PES study.
Warren Clements1,2,3, Matthew W Lukies1,2,4, Madeleine Coleman1
1Department of Radiology, Alfred Health, Melbourne, VIC 3004, Australia.
The British Journal of Radiology
|February 19, 2025
Summary
Clinically significant post-embolization syndrome (csPES) affects nearly half of patients after uterine artery embolization (UAE) for fibroids. Nulliparity is a significant risk factor for developing csPES.
Area of Science:
- Interventional Radiology
- Gynecology
- Vascular Medicine
Background:
- Uterine artery embolization (UAE) is a common treatment for symptomatic uterine fibroids.
- Post-embolization syndrome (PES) is a known complication, but rates of clinically significant PES (csPES) and associated risk factors require further elucidation.
Purpose of the Study:
- To determine the incidence of csPES in patients undergoing UAE for symptomatic fibroids.
- To identify patient-specific risk factors predictive of csPES development.
Main Methods:
- Retrospective case-control study including 69 patients who underwent UAE for symptomatic fibroids.
- csPES defined by pain score >5, elevated PCA morphine use, fever, or multiple antiemetics.
- Logistic regression analysis used to identify risk factors.
Main Results:
- The overall rate of csPES was 47.8% (33/69 patients).
- Nulliparity was significantly associated with an increased risk of csPES (OR: 5.51, P=.021).
- A trend suggested older age may be associated with a reduced risk of csPES (OR: 0.87, P=.054).
Conclusions:
- csPES is a frequent complication following UAE for fibroids.
- Nulliparity emerges as a novel and significant risk factor for csPES.
- Findings can inform pre-procedure patient counseling and targeted interventions for high-risk individuals.
More Related Videos
Related Concept Videos
Pulmonary Embolism I: Introduction
1.5K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.5K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
760
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
760
Pulmonary Embolism III: Nursing Management
756
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
756

